EUVIMEDEUVIMED entdecken
Crossref

Serum sclerostin levels in children with osteogenesis imperfecta

Susanna Reincke iD, Mirko Rehberg, Stefanie Stasek, Shino Junghänel-Welzing, Vera Fuessgen iD, Oliver Semler iD, Heike Hoyer-Kuhn

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · 28.06.2026

DOI: 10.1177/00045632261467690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, online erschienen am 28.06.2026. Verfasst von Susanna Reincke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Die Arbeit nennt 53 Literaturangaben. Gefördert von: ‘Ein Herz für Kinder’ Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Sclerostin inhibits bone formation via the WNT/β-catenin pathway and is a therapeutic target in osteoporosis. Antibodies against sclerostin are currently under investigation for the treatment of osteogenesis imperfecta (OI), a rare, genetically and clinically heterogeneous bone fragility disorder. However, data on serum sclerostin levels in pediatric and adolescent patients with OI remain limited.

Design

This is a retrospective, cross-sectional analysis of serum sclerostin levels in a genetically heterogeneous cohort of children and adolescents with OI. Patients and methods 80 serum samples from 74 OI patients (median age 8.9 years, range 0.1–20.7 years), classified by clinical severity and affected gene, were collected. Serum levels of sclerostin, osteoprotegerin (OPG), parathyroid hormone (PTH), alkaline phosphatase (AP) and 25-Hydroxy Vitamin D (25(OH)D) were measured and analyzed according to genotype and OI severity.

Results

The median serum sclerostin level in this cohort was 0.35 ng/mL (IQR 0.28–0.52). Disease severity showed an inverse correlation with serum sclerostin levels (Spearman ρ = −0.4547, 95% CI [−0.62, −0.25], P < 0.0001). Multivariable linear regression analysis revealed genotype-specific differences in sclerostin levels, particularly in patients with BMP1 or WNT1 mutations compared with other mutation subgroups. No significant correlations were found between sclerostin and OPG, PTH, 25(OH)D, or AP.

Conclusions

In this cohort of children and adolescents with OI, disease severity was inversely associated with serum sclerostin levels, and genotype-specific differences may reflect distinct pathophysiological mechanisms of bone metabolism. These findings may contribute identifying patient subgroups most likely to benefit from targeted anti-sclerostin therapies.

Schlagwörter

Stichwörter der Autor:innen

BMP1Osteogenesis imperfectaWNT1osteoanabolic treatmentsclerostin

Autor:innen und Institutionen

  • Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

ORCID-Profile: Susanna Reincke, Vera Fuessgen, Oliver Semler

Förderung

  • ‘Ein Herz für Kinder’ Foundation

Zitieren

APA

Reincke, S., Rehberg, M., Stasek, S., Junghänel-Welzing, S., Fuessgen, V., Semler, O., & Hoyer-Kuhn, H. (2026). Serum sclerostin levels in children with osteogenesis imperfecta. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. https://doi.org/10.1177/00045632261467690

Vancouver

Reincke S, Rehberg M, Stasek S, Junghänel-Welzing S, Fuessgen V, Semler O, et al. Serum sclerostin levels in children with osteogenesis imperfecta. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 2026. doi:10.1177/00045632261467690

BibTeX
@article{Reincke2026,
  author = {Reincke, Susanna and Rehberg, Mirko and Stasek, Stefanie and Junghänel-Welzing, Shino and Fuessgen, Vera and Semler, Oliver and Hoyer-Kuhn, Heike},
  title = {Serum sclerostin levels in children with osteogenesis imperfecta},
  journal = {Annals of Clinical Biochemistry: International Journal of Laboratory Medicine},
  year = {2026},
  doi = {10.1177/00045632261467690}
}
Kostenlos starten →